CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

IKTInhibikase Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $2.06 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$286.75M
CountryUSA
RECENT INSIDER TRADES
  • 2025-11-24 · Sands Capital Life Sciences Pulse Fund II, L.P. (10% Owner) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders109
Shares held122,441,668
Value$248.38M
Percent of shares outstanding87.75%
As of quarter end2026-06-30
RECENT NEWS
  • Inhibikase grants 128,000 stock options to two new employees
  • Inhibikase Therapeutics, Inc. · 8-K (7.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Inhibikase Therapeutics, Inc. (IKT) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit